EA
NVO

Edge Advisors’s Novo Nordisk NVO Stock Holding History

Edge Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$89K Hold
3,890
– – 0.01% 419
2018
Q1 		$95K Buy
3,890
+1,800
+86% +$47.3K 0.01% 414
2017
Q4 		$56K Sell
2,090
-3,830
-65% -$97.4K 0.01% 506
2017
Q3 		$142K Hold
5,920
– – 0.02% 346
2017
Q2 		$126K Buy
5,920
+820
+16% +$16.5K 0.01% 365
2017
Q1 		$87K Hold
5,100
– – 0.01% 432
2016
Q4 		$91K Buy
+5,100
New +$92.5K 0.01% 395

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Edge Advisors's NVO Position: Q2 2018 in Review

Edge Advisors held its Novo Nordisk (NVO) position steady in Q2 2018 at 3,890 shares worth $89K. The position accounts for 0.01% of the portfolio, ranked #419.

Edge Advisors first reported a position in NVO in Q4 2016 and has held it in 7 quarters since. The position peaked at $142K in Q3 2017. 537 funds tracked by Wall St. Rank hold NVO as of Q2 2018.

  • Edge Advisors held 3,890 shares of Novo Nordisk worth $89K as of Q2 2018.
  • Edge Advisors left its Novo Nordisk share count unchanged in Q2 2018.
  • Novo Nordisk made up 0.01% of Edge Advisors's portfolio in Q2 2018, its #419 holding.
  • Edge Advisors first reported a position in Novo Nordisk in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Novo Nordisk position peaked at $142K in Q3 2017.
  • 537 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.